Olympus Corporation is engaged in the manufacture and sale of precision machineries and instruments. The Company's segments include Medical Business, Scientific Solutions Business, Imaging Business and Others. The Company's Medical Business manufactures and sells medical endoscopes, surgical endoscopes, endotherapy devices and other products. Its Scientific Solutions Business manufactures and sells biological microscopes, industrial microscopes, industrial endoscopes, non-destructive testing equipment and other products. Its Imaging Business manufactures and sells digital cameras, voice recorders and other products. Its Others Business manufactures and sells biomedical materials, conducts system development and other business activities. Its technologies include optical technologies, electronic imaging technologies, precision technologies and biological based technologies. It has a service network consisting of over 200 sites on approximately six continents.
Industry, Sector and Symbol:
Capitalization:- Market Cap: $11.78858 billion
- Outstanding Shares: 342,235,000
Average Prices:- 50 Day Moving Avg: $34.83
- 200 Day Moving Avg: $36.66
- 52 Week Range: $33.17 - $39.49
P/E:- Trailing P/E Ratio: 16.014
- Foreward P/E Ratio: 22.12
- P/E Growth: 0.000
Sales & Book Value:- Annual Revenue: $6.91 billion
- Price / Sales: 1.70
- Book Value: $10.79 per share
- Price / Book: 3.18
Dividend:- Annual Dividend: $0.20
- Dividend Yield: 0.6%
Profitability:- EBIDTA: $1.21 billion
- Net Margins: 10.31%
- Return on Equity: 14.58%
- Return on Assets: 5.92%
Debt:- Debt-to-Equity Ratio: 0.50%
- Current Ratio: 2.01%
- Quick Ratio: 1.56%
Misc:- Average Volume: 19,658 shs.
- Beta: 1.1
Frequently Asked Questions for Olympus Corp. (OTCMKTS:OCPNY)
What is Olympus Corp.'s stock symbol?
Olympus Corp. trades on the OTCMKTS under the ticker symbol "OCPNY."
How were Olympus Corp.'s earnings last quarter?
Olympus Corp. (OTCMKTS:OCPNY) released its quarterly earnings results on Friday, February, 7th. The company reported $0.42 EPS for the quarter. Olympus Corp. had a net margin of 10.31% and a return on equity of 14.58%. View Olympus Corp.'s Earnings History.
When will Olympus Corp. make its next earnings announcement?
Who are some of Olympus Corp.'s key competitors?
Some companies that are related to Olympus Corp. include Zimmer Biomet Holdings (ZBH), Edwards Lifesciences Corporation (EW), C.R. Bard (BCR), Cerner Corporation (CERN), Cardinal Health (CAH), Quintiles Transitional Holdings (Q), AmerisourceBergen Corporation (Holding Co) (ABC), Mylan N.V. (MYL), Lonza Group Ag (LZAGY), BioMarin Pharmaceutical (BMRN), Laboratory Corporation of America Holdings (LH), Centene Corporation (CNC), Smith & Nephew SNATS (SNN), Align Technology (ALGN), Eisai Co., Ltd (ESALY), Quest Diagnostics Incorporated (DGX), Genmab A/S (GNMSF) and IDEXX Laboratories (IDXX).
Who are Olympus Corp.'s key executives?
Olympus Corp.'s management team includes the folowing people:
- Hiroyuki Sasa, Executive President, Representative Director
- Yasuo Takeuchi, Chief Financial Officer, Executive Vice President, Chairman of Subsidiary, Director
- Haruo Ogawa, Chief Technology Officer, Senior Managing Executive Officer, Manager of Technology Development, Director
- Kiichi Hirata, Chief Administrative Officer, Managing Executive Officer, Director
- Akihiro Taguchi, Senior Managing Executive Officer, Manager of Sales & Marketing, Director
- Shigeo Hayashi, Senior Managing Executive Officer, Manager of Manufacturing
- Nobuhiro Abe, Managing Executive Officer
- Naohiko Kawamata, Managing Executive Officer, Chief Director of Procurement
- Yasushi Sakai, Managing Executive Officer, Chief Improvement Officer
- Toshihiko Ohkubo, Executive Officer, Chief Director of Scientific Marketing, Manager of Scientific Business Unit
How do I buy Olympus Corp. stock?
Shares of Olympus Corp. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Olympus Corp.'s stock price today?
One share of Olympus Corp. stock can currently be purchased for approximately $34.29.
MarketBeat Community Rating for Olympus Corp. (OTCMKTS OCPNY)MarketBeat's community ratings are surveys of what our community members think about Olympus Corp. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Olympus Corp. (OTCMKTS:OCPNY) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | No ratings tracked in the last 12 months. |
| Consensus Rating: | N/A (Score: NaN) |
| Consensus Price Target: | N/A |
Analysts' Ratings History for Olympus Corp. (OTCMKTS:OCPNY)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Olympus Corp. (OTCMKTS:OCPNY)Earnings History by Quarter for Olympus Corp. (OTCMKTS OCPNY)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 9/27/2017 | | | | | | | | |
| 2/7/2014 | Q4 | | $0.42 | | | View | N/A |  |
(Data available from 1/1/2011 forward)
Earnings Estimates for Olympus Corp. (OTCMKTS:OCPNY)Current Year EPS Consensus Estimate: $1.47 EPS
Next Year EPS Consensus Estimate: $1.55 EPS
Dividend History for Olympus Corp. (OTCMKTS:OCPNY)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Olympus Corp. (OTCMKTS:OCPNY)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Olympus Corp. (OTCMKTS:OCPNY)
Latest Headlines for Olympus Corp. (OTCMKTS:OCPNY)
| Source: |
|
| Date | Headline |
|---|
 | ETFs with exposure to Olympus Corp. : August 4, 2017
finance.yahoo.com - August 5 at 5:15 AM |
 | Jury orders Olympus to pay $6.6 million but rejects claims its medical scopes are unsafe
www.latimes.com - July 25 at 8:17 AM |
| ETFs with exposure to Olympus Corp. : July 12, 2017
finance.yahoo.com - July 13 at 7:32 AM |
| Olympus Corp. :OCPNY-US: Earnings Analysis: Q4, 2017 By the Numbers : July 11, 2017
finance.yahoo.com - July 12 at 6:33 AM |
 | Olympus Corp (OCPNY) Rating Lowered to Strong Sell at Zacks Investment Research
www.americanbankingnews.com - May 27 at 7:46 AM |
| Olympus Corp (OCPNY) Raised to "Buy" at Zacks Investment Research
www.americanbankingnews.com - May 14 at 8:58 PM |
| Olympus Corp (OCPNY) Cut to "Hold" at Zacks Investment Research
www.americanbankingnews.com - May 9 at 7:34 AM |
| ETFs with exposure to Olympus Corp. : April 7, 2017
finance.yahoo.com - April 7 at 7:24 PM |
| Olympus executives plead the 5th when questioned about the deadly outbreaks tied to the company's medical scopes
www.latimes.com - December 19 at 10:04 AM |
 | Boston Scientific Unveils Improved Endoclip (BSX)
www.investopedia.com - October 19 at 11:38 AM |
| Congressman calls on Japanese prosecutors to probe Olympus over scope infections
www.latimes.com - September 1 at 6:52 PM |
| Olympus Eyes M&A in Ongoing Recovery
finance.yahoo.com - July 20 at 9:30 PM |
| The Zacks Analyst Blog Highlights: Honda Motor, Toyota Motor, Canon and Olympus
finance.yahoo.com - July 14 at 9:30 AM |
| Olympus Corporation of the Americas Enters Into US And Canada Distribution Agreement With Arc Medical Design Ltd, A Subsidiary Of Norgine For ENDOCUFF VISION®
finance.yahoo.com - May 6 at 8:00 AM |
 | [video]Olympus Teams Up With Sony for Surgical Big Screen TV
www.thestreet.com - April 9 at 10:26 PM |
| Olympus sought price hike for UCLA amid superbug outbreak
www.latimes.com - March 25 at 6:04 AM |
 | Whistleblower Delivers A Triple Whammy To Olympus; More Companies Might Get Hit
www.forbes.com - March 4 at 5:45 PM |
| Olympus to pay at least $635 million to settle kickback and bribery cases
www.latimes.com - March 1 at 2:20 PM |
 | Olympus Will Pay $646 Million to End Kickback, Bribe Probes
www.bloomberg.com - March 1 at 10:27 AM |
| Olympus settles with Japan whistleblower after 8-year battle
finance.yahoo.com - February 18 at 2:34 AM |
 | FDA Approves Fixes for Olympus Scope Linked to Infections
www.wsj.com - January 17 at 7:57 PM |
| Olympus to recall and redesign medical scope linked to superbug outbreaks
www.latimes.com - January 15 at 1:04 PM |
| Ex-Olympus CEO Woodford Sues Company for Breach of Contract
www.bloomberg.com - January 15 at 12:59 PM |
 | Congressman wants SEC probe into Olympus over superbug outbreak
www.bizjournals.com - December 23 at 4:00 PM |
| Medtronic-Samsung to Advance Neuromodulation Therapy
finance.yahoo.com - December 14 at 2:20 PM |
| Becton, Dickinson Unveils BD FACSCelesta Flow Cytometer
finance.yahoo.com - December 14 at 1:20 PM |
| St. Jude Medical Unveils Positive Data from SUNBURST Study
finance.yahoo.com - December 14 at 1:10 PM |
| FDA OKs Medtronic Activa DBS System for Full-Body MRI Scan
finance.yahoo.com - December 11 at 2:10 PM |
| Edwards Lifesciences Reveals 2016 and Long-Term Outlook
finance.yahoo.com - December 10 at 2:15 PM |
| athenahealth Unveils 2016 Outlook; 2015 Projections Intact
finance.yahoo.com - December 10 at 1:00 PM |
| Becton, Dickinson IV Solution to Aid Medication Management
finance.yahoo.com - December 9 at 12:50 PM |
| Allscripts (MDRX) Rides High on Partnerships, Customer Wins
finance.yahoo.com - December 8 at 9:50 AM |
| Cerner's HealtheIntent on a Roll: Wins a String of Contracts
finance.yahoo.com - December 7 at 4:45 PM |
| St. Jude Receives CE Mark for MRI on Quadra Assura CRT-D
finance.yahoo.com - December 7 at 4:05 PM |
| Cooper Companies Q4 Earnings, Revenues Lag; Stock Down
finance.yahoo.com - December 4 at 10:10 AM |
Olympus Corp. (OCPNY) Chart for Friday, September, 22, 2017
